Merck Responds To Journal Of The American Medical Association Articles

Merck & Co., Inc. today said it is committed tohigh standards of scientific integrity and ethics, and believes that many of the comments in aJournal of the American Medical Association (JAMA) news release and in the April 16 issue ofJAMA1 related to VIOXX are false, misleading or lack context. The Company said it was notgiven an opportunity to respond prior to publication.

More: continued here

Filed under: Arthritis on April 17th, 2008